Page last updated: 2024-09-03

sauristolactam and Cancer of Mouth

sauristolactam has been researched along with Cancer of Mouth in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, NP; Cho, SD; Choi, ES; Choi, KH; Han, HS; Kim, JH; Kim, KA; Kong, G; Kwon, KH; Leem, DH; Min, YK; Nam, JS; Oh, SH; Shim, JH; Shin, JA	1

Other Studies

1 other study(ies) available for sauristolactam and Cancer of Mouth

Article	Year
KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2010, Volume: 19, Issue:1 Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Down-Regulation; Drug Evaluation, Preclinical; Gene Expression Regulation, Enzymologic; Humans; Isoindoles; KB Cells; Lactams; Mouth Neoplasms; Phenanthrenes; Pyrazoles; Sulfonamides	2010

Article

Year

KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2010, Volume: 19, Issue:1

Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Down-Regulation; Drug Evaluation, Preclinical; Gene Expression Regulation, Enzymologic; Humans; Isoindoles; KB Cells; Lactams; Mouth Neoplasms; Phenanthrenes; Pyrazoles; Sulfonamides

2010